The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...
Hepzato Kit, FDA-approved for metastatic uveal melanoma liver treatment, shows strong early revenue ($10M in Q3, $13.7M expected in Q4) with surprising profitability. The disease affects ~1,700 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback